Singapore markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6900-0.0100 (-0.27%)
At close: 04:00PM EDT
3.7200 +0.03 (+0.81%)
After hours: 05:17PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-131,223
-135,956
-115,909
121,190
-10,947
Depreciation & amortisation
416
416
260
29
19
Stock-based compensation
48,916
49,428
46,718
39,621
7,457
Change in working capital
10,886
16,163
-46,586
-247,845
300,205
Accounts receivable
-
-
-
-
-5,815
Accounts payable
-723
1,701
-1,983
10,289
-488
Other working capital
-85,106
-85,395
-122,925
-87,009
296,708
Net cash provided by operating activities
-85,106
-85,395
-120,982
-87,005
296,734
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-1,943
-4
-26
Purchases of investments
-573,529
-562,362
-545,352
0
0
Sales/maturities of investments
619,549
602,665
91,885
0
0
Net cash used for investing activities
46,020
40,303
-455,410
-4
-26
Cash flows from financing activities
Common stock issued
-
-
230
1,465
317,632
Net cash used provided by (used for) financing activities
257
257
370
1,465
531,748
Net change in cash
-38,829
-44,835
-576,022
-85,544
828,456
Cash at beginning of period
176,715
188,658
764,680
850,224
21,768
Cash at end of period
137,886
143,823
188,658
764,680
850,224
Free cash flow
Operating cash flow
-85,106
-85,395
-120,982
-87,005
296,734
Capital expenditure
-
-
-1,943
-4
-26
Free cash flow
-85,106
-85,395
-122,925
-87,009
296,708